journal article·2025-09Open access

The Role of HINT3 in Myocardial Ischemia‐Reperfusion Injury in Male Mice: Mechanisms Involving SDHA and its Acetylation

Jiabin Yu, Qi Yao, Tongtong Hu, Yadan Zhang, Ying Liu, Yang Xiao, Qingqing Wu, Qizhu Tang

Advanced Science· Volume 12· Issue 33

Abstract

Abstract Myocardial ischemia‐reperfusion (I/R) injury is characterized by oxidative stress, mitochondrial dysfunction, and cardiomyocyte apoptosis. During I/R, the accumulation and oxidation of succinate contribute to reactive oxygen species (ROS) production, worsening tissue damage. Histidine triad nucleotide‐binding protein 3 (HINT3) is identified as a regulator of mitochondrial function and cardiomyocyte survival during I/R. In a mouse I/R model and an oxygen‐glucose deprivation/reoxygenation (OGD/R) model, it shows that HINT3 expression is downregulated after I/R. Cardiomyocyte‐specific knockout of HINT3 exacerbates myocardial injury, impairs cardiac function, and promotes mitochondrial dysfunction and apoptosis, whereas HINT3 overexpression mitigates these effects. Mechanistically, HINT3 interacts with succinate dehydrogenase subunit A (SDHA), suppresses HDAC1 expression, and prevents SDHA deacetylation at K335, reducing SDH activity and mitochondrial ROS production. These findings highlight the HINT3‐HDAC1‐SDHA axis as a key pathway in mitochondrial regulation, offering new insights and therapeutic targets for myocardial reperfusion injury.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Histone Deacetylase Inhibitors Research · Signaling Pathways in Disease · Cardiac Ischemia and Reperfusion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiology Renmin Hospital of Wuhan University Wuhan 430060 P. R. China

Hubei Key Laboratory of Metabolic and Chronic Diseases Wuhan 430060 P. R. China

Taikang Center for Life and Medical Sciences Taikang Medical School Wuhan University Wuhan 430072 P. R. China

Funding

National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1016/j.jacc.2024.02.05610.1016/j.jacc.2024.02.056 ↗
2. 10.1161/CIRCRESAHA.121.32071710.1161/CIRCRESAHA.121.320717 ↗
3. 10.1161/01.CIR.91.6.187210.1161/01.CIR.91.6.1872 ↗
4. 10.1038/s41467-023-39027-x10.1038/s41467-023-39027-x ↗
5. 10.7150/thno.7512110.7150/thno.75121 ↗
6. 10.1093/eurheartj/ehz11510.1093/eurheartj/ehz115 ↗
7. 10.1016/j.cmet.2015.12.00910.1016/j.cmet.2015.12.009 ↗
8. 10.1152/physrev.00024.200710.1152/physrev.00024.2007 ↗
9. 10.1161/CIRCRESAHA.109.19799610.1161/CIRCRESAHA.109.197996 ↗
10. 10.1021/bi025942q10.1021/bi025942q ↗
11. 10.3892/ijmm.2023.525710.3892/ijmm.2023.5257 ↗
12. 10.1038/s12276-020-0465-210.1038/s12276-020-0465-2 ↗
13. 10.1161/CIRCULATIONAHA.120.05109410.1161/CIRCULATIONAHA.120.051094 ↗
14. 10.1111/jcmm.1827610.1111/jcmm.18276 ↗
15. 10.1038/nature1390910.1038/nature13909 ↗
16. 10.1038/s41467-021-20942-w10.1038/s41467-021-20942-w ↗
17. 10.1038/nm.321210.1038/nm.3212 ↗
18. 10.1016/j.redox.2024.10316110.1016/j.redox.2024.103161 ↗
19. 10.1016/j.redox.2023.10260010.1016/j.redox.2023.102600 ↗
20. 10.1007/s00395-024-01063-z10.1007/s00395-024-01063-z ↗
21. 10.1016/j.freeradbiomed.2024.03.01110.1016/j.freeradbiomed.2024.03.011 ↗
22. 10.1016/j.redox.2024.10344310.1016/j.redox.2024.103443 ↗
23. 10.1016/j.redox.2024.10340610.1016/j.redox.2024.103406 ↗
24. 10.1038/s41418-024-01386-310.1038/s41418-024-01386-3 ↗
25. 10.1093/eurheartj/ehae10710.1093/eurheartj/ehae107 ↗
26. 10.1016/j.jacc.2020.12.06010.1016/j.jacc.2020.12.060 ↗
27. 10.15252/emmm.20201342710.15252/emmm.202013427 ↗
28. 10.1371/journal.pone.002329510.1371/journal.pone.0023295 ↗
29. 10.1038/s42255-020-0179-810.1038/s42255-020-0179-8 ↗
30. 10.1016/j.celrep.2023.11204110.1016/j.celrep.2023.112041 ↗
31. 10.1016/j.celrep.2018.05.01310.1016/j.celrep.2018.05.013 ↗
32. 10.1016/j.freeradbiomed.2019.01.03010.1016/j.freeradbiomed.2019.01.030 ↗
33. 10.1016/j.yjmcc.2017.12.00410.1016/j.yjmcc.2017.12.004 ↗
34. 10.1161/CIRCULATIONAHA.118.03625910.1161/CIRCULATIONAHA.118.036259 ↗
35. 10.1161/CIRCRESAHA.124.32380010.1161/CIRCRESAHA.124.323800 ↗
36. 10.1016/j.metabol.2022.15531310.1016/j.metabol.2022.155313 ↗
37. 10.3390/nu1523485910.3390/nu15234859 ↗
38. 10.1007/s00395-021-00905-410.1007/s00395-021-00905-4 ↗
39. 10.1152/ajpheart.00259.201910.1152/ajpheart.00259.2019 ↗
40. 10.1111/jcmm.1512710.1111/jcmm.15127 ↗
41. 10.1038/s41569-020-0403-y10.1038/s41569-020-0403-y ↗
42. 10.1097/PAT.0b013e328353993210.1097/PAT.0b013e3283539932 ↗
43. 10.1016/j.bbabio.2016.03.01210.1016/j.bbabio.2016.03.012 ↗
44. 10.1007/s12035-023-03830-w10.1007/s12035-023-03830-w ↗
45. 10.1038/s41388-023-02656-z10.1038/s41388-023-02656-z ↗
46. 10.1038/s41569-022-00797-410.1038/s41569-022-00797-4 ↗
47. 10.1016/j.metabol.2023.15565810.1016/j.metabol.2023.155658 ↗
48. 10.1038/s41467-023-39159-010.1038/s41467-023-39159-0 ↗
49. 10.1093/cvr/cvae07710.1093/cvr/cvae077 ↗
50. 10.1161/CIRCULATIONAHA.123.06560310.1161/CIRCULATIONAHA.123.065603 ↗